Label-free metabolic imaging for sensitive and robust monitoring of anti-CD47 immunotherapy response in triple-negative breast cancer

BACKGROUND: Immunotherapy is revolutionizing cancer treatment from conventional radiotherapies and chemotherapies to immune checkpoint inhibitors which use patients’ immune system to recognize and attack cancer cells. Despite the huge clinical success and vigorous development of immunotherapies, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Minfeng, Mahanty, Arpan, Jin, Chunjing, Wong, Alex Ngai Nick, Yoo, Jung Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472253/
https://www.ncbi.nlm.nih.gov/pubmed/36096527
http://dx.doi.org/10.1136/jitc-2022-005199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472253/
https://www.ncbi.nlm.nih.gov/pubmed/36096527
http://dx.doi.org/10.1136/jitc-2022-005199

Ejemplares similares